142
Views
62
CrossRef citations to date
0
Altmetric
Review

Danish Breast Cancer Cooperative Group

, , &
Pages 445-449 | Published online: 25 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Else Helene Ibfelt, Henry Jensen, Birgitte Vrou Offersen, Maiken Bang Hansen, Henrik Møller, Peer Christiansen & Tina Bech Olesen. (2023) Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study. Acta Oncologica 62:12, pages 1749-1756.
Read now
Cecilie Larsen, Kirstine S. Kirchhoff, Lena Saltbæk, Lau C. Thygesen, Randi V. Karlsen, Mads N. Svendsen, Beverley L. Høeg, Trine A. Horsbøl, Pernille E. Bidstrup, Helle G. Christensen, Christoffer Johansen & Susanne O. Dalton. (2023) The association between education and fear of recurrence among breast cancer patients in follow-up – and the mediating effect of self-efficacy. Acta Oncologica 62:7, pages 714-718.
Read now
Anne Marie Kirkegaard, Susanne Oksbjerg Dalton, Ellen Helle Boesen, Randi V. Karlsen, Henrik Flyger, Christoffer Johansen & Annika von Heymann. (2023) Effects on long-term survival of psychosocial group intervention in early-stage breast cancer: follow-up of a randomized controlled trial. Acta Oncologica 62:4, pages 422-428.
Read now
Andreas David Lauritzen, Tobias Berg, Maj-Britt Jensen, Martin Lillholm & Ann Knoop. (2023) Identifying recurrent breast cancer patients in national health registries using machine learning. Acta Oncologica 62:4, pages 350-357.
Read now
Caroline Wium Hansen, Marianne Vogsen & Annette Raskov Kodahl. (2022) Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women. Acta Oncologica 61:11, pages 1362-1368.
Read now
Julie Barberio, Thomas P Ahern, Richard F MacLehose, Lindsay J Collin, Deirdre P Cronin-Fenton, Per Damkier, Henrik Toft Sørensen & Timothy L Lash. (2021) Assessing Techniques for Quantifying the Impact of Bias Due to an Unmeasured Confounder: An Applied Example. Clinical Epidemiology 13, pages 627-635.
Read now
Nina Gran Egeland, Kristin Jonsdottir, Kristina Lystlund Lauridsen, Ivar Skaland, Cathrine F Hjorth, Einar G Gudlaugsson, Stephen Hamilton-Dutoit, Timothy L Lash, Deirdre Cronin-Fenton & Emiel A M Janssen. (2020) Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients. Clinical Epidemiology 12, pages 771-781.
Read now
Mef Nilbert, Linda Aagaard Thomsen, Jens Winther Jensen, Henrik Møller, Michael Borre, Arvid Widenlou Nordmark, Mats Lambe, Helena Brändström, Hartwig Kørner, Bjørn Møller & Giske Ursin. (2020) The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care. Acta Oncologica 59:11, pages 1343-1356.
Read now
Marianne Vogsen, Camilla Bille, Anne Marie Bak Jylling, Maj-Britt Jensen & Marianne Ewertz. (2020) Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008–2012. Acta Oncologica 59:7, pages 741-747.
Read now
Morten Schmidt, Sigrun Alba Johannesdottir Schmidt, Kasper Adelborg, Jens Sundbøll, Kristina Laugesen, Vera Ehrenstein & Henrik Toft Sørensen. (2019) The Danish health care system and epidemiological research: from health care contacts to database records. Clinical Epidemiology 11, pages 563-591.
Read now
I. M. H. Sønderstrup, M. B. Jensen, B. Ejlertsen, J. O. Eriksen, A. M. Gerdes, T. A. Kruse, M. J. Larsen, M. Thomassen & A. V. Laenkholm. (2019) Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer. Acta Oncologica 58:3, pages 363-370.
Read now
Marianne Ewertz, Lotte Holm Land, Susanne Oksbjerg Dalton, Deirdre Cronin-Fenton & Maj-Britt Jensen. (2018) Influence of specific comorbidities on survival after early-stage breast cancer. Acta Oncologica 57:1, pages 129-134.
Read now
Deirdre Cronin-Fenton, Timothy L. Lash, Thomas P. Ahern, Per Damkier, Peer Christiansen, Bent Ejlertsen & Henrik T. Sørensen. (2018) Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database. Acta Oncologica 57:1, pages 120-128.
Read now
Anne-Vibeke Laenkholm, Maj-Britt Jensen, Jens Ole Eriksen, Wesley Buckingham, Sean Ferree, Torsten O. Nielsen & Bent Ejlertsen. (2018) The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes. Acta Oncologica 57:1, pages 44-50.
Read now
Signe Korsgaard Skriver, Anne-Vibeke Laenkholm, Birgitte Bruun Rasmussen, Jürgen Handler, Bo Grundtmann, Tove Filtenborg Tvedskov, Peer Christiansen, Ann S. Knoop, Maj-Britt Jensen & Bent Ejlertsen. (2018) Neoadjuvant letrozole for postmenopausal estrogen receptor-positive, HER2-negative breast cancer patients, a study from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica 57:1, pages 31-37.
Read now
I. M. H. Soenderstrup, A. V. Laenkholm, M. B. Jensen, J. O. Eriksen, A. M. Gerdes, T. V. O. Hansen, T. A. Kruse, M. J. Larsen, I. S. Pedersen, M. Rossing, M. Thomassen & B. Ejlertsen. (2018) Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG. Acta Oncologica 57:1, pages 95-101.
Read now

Articles from other publishers (46)

Mads G. Jørgensen, Ebru Gözeri, Tanja G. Petersen & Jens A. Sørensen. (2023) Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study. Clinical Breast Cancer 23:5, pages e296-e304.e2.
Crossref
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre Cronin-Fenton, Peer Christiansen & Bent Ejlertsen. (2023) Response to Pederson et al. and Chlebowski et al.. JNCI: Journal of the National Cancer Institute 115:2, pages 229-230.
Crossref
Mathilde Gottschau, Susanne K. Kjær, Jakob Hansen Viuff, Allan Jensen, Christian Munk, Annette Settnes & Lene Mellemkjær. (2022) Ovarian removal and subsequent breast cancer prognosis: a nationwide cohort study. Breast Cancer Research and Treatment 197:3, pages 583-591.
Crossref
Line Flytkjær Virgilsen, Peter Vedsted, Alina Zalounina Falborg, Anette Fischer Pedersen, Anders Prior & Henry Jensen. (2022) Routes to cancer diagnosis for patients with pre-existing psychiatric disorders: a nationwide register-based cohort study. BMC Cancer 22:1.
Crossref
Line Flytkjær Virgilsen, Alina Zalounina Falborg, Peter Vedsted, Anders Prior, Anette Fischer Pedersen & Henry Jensen. (2022) Unplanned cancer presentation in patients with psychiatric disorders: A nationwide register-based cohort study in Denmark. Cancer Epidemiology 81, pages 102293.
Crossref
Dorthe C. Pedersen, Britt W. Jensen, Anne Tjønneland, Zorana J. Andersen, Lene Mellemkjaer, Lise G. Bjerregaard, Julie Aarestrup & Jennifer L. Baker. (2022) Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes. Breast Cancer Research 24:1.
Crossref
Stine Thestrup Hansen, Karin Piil, Lone Bak Hansen, Karen Marie Ledertoug, Bibi Hølge-Hazelton & Volker Jürgen Schmidt. (2022) Electronic patient-reported outcome measures to enable systematic follow-up in treatment and care of women diagnosed with breast cancer: a feasibility study protocol. BMJ Open 12:11, pages e065110.
Crossref
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre Cronin-Fenton, Peer Christiansen & Bent Ejlertsen. (2022) Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study. JNCI: Journal of the National Cancer Institute 114:10, pages 1347-1354.
Crossref
B. Danckert, N. L. Christensen, A. Z. Falborg, H. Frederiksen, G. Lyratzopoulos, S. McPhail, A. F. Pedersen, J. Ryg, L. A. Thomsen, P. Vedsted & H. Jensen. (2022) Assessing how routes to diagnosis vary by the age of patients with cancer: a nationwide register-based cohort study in Denmark. BMC Cancer 22:1.
Crossref
Aivara Urbute, Kirsten Frederiksen & Susanne K. Kjaer. (2022) Early adulthood overweight and obesity and risk of premenopausal ovarian cancer, and premenopausal breast cancer including receptor status: prospective cohort study of nearly 500,000 Danish women. Annals of Epidemiology 70, pages 61-67.
Crossref
Elise Dumas, Lucie Laot, Florence Coussy, Beatriz Grandal Rejo, Eric Daoud, Enora Laas, Amyn Kassara, Alena Majdling, Rayan Kabirian, Floriane Jochum, Paul Gougis, Sophie Michel, Sophie Houzard, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Judicaël Hotton, Chloé-Agathe Azencott, Fabien Reyal & Anne-Sophie Hamy. (2022) The French Early Breast Cancer Cohort (FRESH): A Resource for Breast Cancer Research and Evaluations of Oncology Practices Based on the French National Healthcare System Database (SNDS). Cancers 14:11, pages 2671.
Crossref
Mathilde Gottschau, Annet Bens, Søren Friis, Deirdre Cronin‐Fenton, Gitte Lerche Aalborg, Maj‐Britt Jensen, Bent Ejlertsen, Niels Kroman & Lene Mellemkjær. (2022) Use of beta‐blockers and risk of contralateral breast cancer. International Journal of Cancer 150:10, pages 1619-1626.
Crossref
Rikke Nørgaard Pedersen, Lene Mellemkjær, Bent Ejlertsen, Mette Nørgaard & Deirdre P. Cronin-Fenton. (2022) Mortality After Late Breast Cancer Recurrence in Denmark. Journal of Clinical Oncology 40:13, pages 1450-1463.
Crossref
Camil Ciprian Mireştean, Roxana Irina Iancu & Dragoş Petru Teodor Iancu. (2022) Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review. Frontiers in Oncology 12.
Crossref
Nanna Jørgensen, Thomas Vauvert F. Hviid, Lise B. Nielsen, Ida M. H. Sønderstrup, Jens Ole Eriksen, Bent Ejlertsen, Anne-Marie Gerdes, Torben A. Kruse, Mads Thomassen, Maj-Britt Jensen & Anne-Vibeke Lænkholm. (2021) Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British Journal of Cancer 125:10, pages 1388-1398.
Crossref
Mads Gustaf Jørgensen, Anne Pernille Hermann, Anette Riis Madsen, Steffanie Christensen & Jens Ahm Sørensen. (2021) Indocyanine green lymphangiography is superior to clinical staging in breast cancer-related lymphedema. Scientific Reports 11:1.
Crossref
Mads Gustaf Jørgensen, Anne Pernille Hermann, Anette Riis Madsen, Steffanie Christensen, Kim Gordon Ingwersen, Jørn Bo Thomsen & Jens Ahm Sørensen. (2021) Cellulitis Is Associated with Severe Breast Cancer-Related Lymphedema: An Observational Study of Tissue Composition. Cancers 13:14, pages 3584.
Crossref
Mads G. Jørgensen, Navid M. Toyserkani, Frederik G. Hansen, Anette Bygum & Jens A. Sørensen. (2021) The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. npj Breast Cancer 7:1.
Crossref
Marie Louise Holm Milo, Lise Bech Jellesmark Thorsen, Søren Paaske Johnsen, Kirsten Melgaard Nielsen, Jan Brink Valentin, Jan Alsner & Birgitte Vrou Offersen. (2021) Risk of coronary artery disease after adjuvant radiotherapy in 29,662 early breast cancer patients: A population-based Danish Breast Cancer Group study. Radiotherapy and Oncology 157, pages 106-113.
Crossref
Mads Gustaf Jørgensen, Navid Mohamadpour Toyserkani, Frederik Christopher Gulmark Hansen, Jørn Bo Thomsen & Jens Ahm Sørensen. (2021) Prospective Validation of Indocyanine Green Lymphangiography Staging of Breast Cancer-Related Lymphedema. Cancers 13:7, pages 1540.
Crossref
Bill Karanatsios, Khic-Houy Prang, Ebony Verbunt, Justin M. Yeung, Margaret Kelaher & Peter Gibbs. (2020) Defining key design elements of registry-based randomised controlled trials: a scoping review. Trials 21:1.
Crossref
Anne Mette Falstie-Jensen, Buket Ö. Esen, Anders Kjærsgaard, Ebbe L. Lorenzen, Jeanette D. Jensen, Kristin V. Reinertsen, Olaf M. Dekkers, Marianne Ewertz & Deirdre P. Cronin-Fenton. (2020) Incidence of hypothyroidism after treatment for breast cancer—a Danish matched cohort study. Breast Cancer Research 22:1.
Crossref
Ebbe Laugaard Lorenzen, Jens Christian Rehammar, Maj-Britt Jensen, Marianne Ewertz & Carsten Brink. (2020) Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977–2005. Radiotherapy and Oncology 152, pages 103-110.
Crossref
Lena Saltbæk, Trine Allerslev Horsboel, Birgitte Vrou Offersen, Michael Andersson, Anne Sofie Friberg, Signe Korsgaard Skriver, Pernille Envold Bidstrup, Jens Overgaard, Christoffer Johansen & Susanne Oksbjerg Dalton. (2020) Patterns in detection of recurrence among patients treated for breast cancer. Breast Cancer Research and Treatment 184:2, pages 365-373.
Crossref
Signe Korsgaard Skriver, Maj-Britt Jensen, Jens-Ole Eriksen, Lise Barlebo Ahlborn, Ann Soegaard Knoop, Maria Rossing, Bent Ejlertsen & Anne-Vibeke Laenkholm. (2020) Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients. Breast Cancer Research and Treatment 184:1, pages 123-133.
Crossref
Anne-Vibeke Lænkholm, Maj-Britt Jensen, Jens Ole Eriksen, Anne Roslind, Wesley Buckingham, Sean Ferree, Torsten Nielsen & Bent Ejlertsen. (2020) Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer. Clinical Breast Cancer 20:4, pages e423-e432.
Crossref
E. Heeg, M. B. Jensen, M. A. M. Mureau, B. Ejlertsen, R. A. E. M. Tollenaar, P. M. Christiansen & M. T. F. D. Vrancken Peeters. (2020) Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands. Breast Cancer Research and Treatment 182:3, pages 709-718.
Crossref
Mathias Kvist Mejdahl, Jan Wohlfahrt, Marianne Holm, Ann Søegaard Knoop, Anne Tjønneland, Mads Melbye, Niels Kroman & Eva Balslev. (2020) Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology. Breast Cancer Research and Treatment 182:1, pages 229-238.
Crossref
Kristine Bennedsgaard, Lise Ventzel, Andreas C. Themistocleous, David L. Bennett, Anders B. Jensen, Anni R. Jensen, Niels T. Andersen, Troels S. Jensen, Hatice Tankisi & Nanna B. Finnerup. (2020) Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy. Cancer Medicine 9:14, pages 5114-5123.
Crossref
Bin Tang, Jiabao Ma, Jinghui Xu, Jie Li, Shengwei Kang, Pei Wang, Fan Wu & Lucia Clara Orlandini. (2020) Feasibility of using calibrated cone-beam computed tomography scans to validate the heart dose in left breast post-mastectomy radiotherapy. Journal of International Medical Research 48:6, pages 030006052092916.
Crossref
Annet Bens, Christian Dehlendorff, Søren Friis, Deirdre Cronin-Fenton, Maj-Britt Jensen, Bent Ejlertsen, Timothy L. Lash, Niels Kroman & Lene Mellemkjær. (2020) The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study. British Journal of Cancer 122:7, pages 1102-1108.
Crossref
Gulsen Pinar Soydemir Gocer & Elif Eda Ozer. (2020) Effect of radiotherapy on coronary arteries and heart in breast-conserving surgery: a dosimetric analysis. Radiology and Oncology 54:1, pages 128-134.
Crossref
Charlotte Kanstrup, Dorthe Teilum, Lars Rejnmark, Janne Villemoes Bigaard, Pia Eiken, Niels Kroman, Anne Tjønneland & Mathias Kvist Mejdahl. (2019) 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival. Breast Cancer Research and Treatment 179:3, pages 699-708.
Crossref
Anne Mette Falstie-Jensen, Anders Kjærsgaard, Ebbe Laugaard Lorenzen, Jeanette Dupont Jensen, Kristin Valborg Reinertsen, Olaf M. Dekkers, Marianne Ewertz & Deirdre P. Cronin-Fenton. (2019) Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study. Breast Cancer Research 21:1.
Crossref
Thomas P. Ahern, Anne Broe, Timothy L. Lash, Deirdre P. Cronin-Fenton, Sinna Pilgaard Ulrichsen, Peer M. Christiansen, Bernard F. Cole, Rulla M. Tamimi, Henrik Toft Sørensen & Per Damkier. (2019) Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study. Journal of Clinical Oncology 37:21, pages 1800-1809.
Crossref
Robert Finnegan, Jason Dowling, Eng-Siew Koh, Simon Tang, James Otton, Geoff Delaney, Vikneswary Batumalai, Carol Luo, Pramukh Atluri, Athiththa Satchithanandha, David Thwaites & Lois Holloway. (2019) Feasibility of multi-atlas cardiac segmentation from thoracic planning CT in a probabilistic framework. Physics in Medicine & Biology 64:8, pages 085006.
Crossref
Mathias Kvist Mejdahl, Jan Wohlfahrt, Marianne Holm, Eva Balslev, Ann Søegaard Knoop, Anne Tjønneland, Mads Melbye & Niels Kroman. (2019) Breast cancer mortality in synchronous bilateral breast cancer patients. British Journal of Cancer 120:7, pages 761-767.
Crossref
Ann Banke, Emil L. Fosbøl, Marianne Ewertz, Lars Videbæk, Jordi S. Dahl, Mikael Kjær Poulsen, Søren Cold, Maj-Britt Jensen, Gunnar H. Gislason, Morten Schou & Jacob E. Møller. (2019) Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab. JACC: Heart Failure 7:3, pages 217-224.
Crossref
Ida Marie H. Sønderstrup, Maj-Britt R. Jensen, Bent Ejlertsen, Jens O. Eriksen, Anne-Marie Gerdes, Torben A. Kruse, Martin J. Larsen, Mads Thomassen & Anne-Vibeke Lænkholm. (2019) Subtypes in BRCA-mutated breast cancer. Human Pathology 84, pages 192-201.
Crossref
Emil Villiam Holm-Rasmussen, Maj-Britt Jensen, Eva Balslev, Niels Kroman & Tove Filtenborg Tvedskov. (2018) Risk factors of sentinel and non-sentinel lymph node metastases in patients with ductal carcinoma in situ of the breast: A nationwide study. The Breast 42, pages 128-132.
Crossref
Rikke Langballe, Deirdre Cronin-Fenton, Christian Dehlendorff, Maj-Britt Jensen, Bent Ejlertsen, Michael Andersson, Søren Friis & Lene Mellemkjær. (2018) Statin use and risk of contralateral breast cancer: a nationwide cohort study. British Journal of Cancer 119:10, pages 1297-1305.
Crossref
Rikke Langballe, Kirsten Frederiksen, Maj-Britt Jensen, Michael Andersson, Deirdre Cronin-Fenton, Bent Ejlertsen & Lene Mellemkjær. (2018) Mortality after contralateral breast cancer in Denmark. Breast Cancer Research and Treatment 171:2, pages 489-499.
Crossref
Anne-Vibeke LænkholmMaj-Britt JensenJens Ole EriksenBirgitte Bruun RasmussenAnn S. KnoopWesley BuckinghamSean FerreeCarl SchaperTorsten O. NielsenTaryn HaffnerTorben KibølMaj-Lis Møller TalmanAnne Marie Bak JyllingTomasz Piotr TaborBent Ejlertsen. (2018) PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor–Positive Early Breast Cancer. Journal of Clinical Oncology 36:8, pages 735-740.
Crossref
Bent EjlertsenMalgorzata K. TuxenErik Hugger JakobsenMaj-Britt JensenAnn Soegaard KnoopInger HøjrisMarianne EwertzEva BalslevHella DanøPeter Michael VestlevJulia KenholmDorte L. NielsenTroels BechmannMichael AnderssonSøren ColdHanne Melgaard NielsenElse MaaeDorte CarlsenHenning T. Mouridsen. (2017) Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A -Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial . Journal of Clinical Oncology 35:23, pages 2639-2646.
Crossref
Jens Christian Rehammar, Maj-Britt Jensen, Paul McGale, Ebbe Laugaard Lorenzen, Carolyn Taylor, Sarah C. Darby, Lars Videbæk, Zhe Wang & Marianne Ewertz. (2017) Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005. Radiotherapy and Oncology 123:2, pages 299-305.
Crossref
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre P. Cronin-Fenton, Peer Christiansen & Bent Ejlertsen. (2021) Vaginal Estrogens in Postmenopausal Women Treated for Early Breast Cancer. An Observational Cohort Study. SSRN Electronic Journal.
Crossref